RE:RE:RE:Benefits and Negative of share repurchase programRosenberg....you just can't accept or won't because it goes against your pumper narrative that the "bubble" has no impact on FSD.....no trials or testing...no revenue...no product....FSD, its BoD, and management are the sole responsible party for its downfall....market trends do not apply....but you'll disagree and argue with some cherry picked article or outright lie....so....what you normally do....
DavidRosenberg wrote: Mil_Man54 wrote: Lets see what we have here and decide whether this buyback is positive or negative....the program is having no positive impact on the SP and is not generating any investment interest in the company.....the CEO is using investor funds in the form of cash on hand to purchase shares and not revenue or profits as there are none which further reduces the money available for testing and trials....Saeed's purchases are a token gesture at best and a weak attempt at trying to reflect confidence in the company ....not to mention the company is days away from receiving the letter of non-compliance from NASDAQ which will undoubtedly have a negative inmpact on the SP.
So based on that and not seeing any positives from this program.....it is definitely having a negative impact.
https://www.nasdaq.com/articles/heres-what-happened-to-biotech-this-year?amp